Gene Solutions and Element Biosciences Collaboration to Enhance NGS Technology

Gene Solutions has announced a strategic collaboration with Element Biosciences. 

The partnership was formalised through the signing of a Memorandum of Understanding (MoU) during a recent visit by Element Biosciences to Gene Solutions’ laboratory.

The alliance is expected to generate significant synergies by combining Element Biosciences’ advanced sequencing platforms with Gene Solutions’ expertise in genetic testing and AI-driven diagnostics. While Element Biosciences continues to establish itself as a key player in the field of next-generation sequencing (NGS), Gene Solutions has built a strong presence across eight Asian countries, delivering genetic solutions to more than 4,500 hospitals and clinics.

One major area of focus in this partnership is reproductive health, particularly non-invasive prenatal testing (NIPT). This widely used clinical application of NGS screens for chromosomal abnormalities in cell-free DNA found in the blood of pregnant women. Gene Solutions has developed its proprietary NIPT solution under the brand triSure™, along with a full ecosystem covering pre-birth to postnatal diagnosis. The company's workflow uniquely integrates screening for both recessive and dominant single-gene disorders, and ongoing research aims to add pregnancy complication prediction into the test.

With the global NIPT market forecast to grow from USD 5.20 billion in 2022 to USD 19.09 billion by 2030, the collaboration seeks to leverage Element’s cost-effective and accessible sequencing tools to further extend the reach of these non-invasive screening options.

In the field of oncology, early detection remains a critical goal. Gene Solutions has introduced several AI-powered genomic tests, including SPOT-MAS for early cancer detection and additional personalised tools for guiding targeted and immunotherapies. These solutions are supported by genomic and transcriptomic profiling and are applied across several stages of cancer care, including continuous monitoring.

This collaboration is set to advance these innovations through the integration of AVITI24™, Element’s comprehensive multiomics platform. AVITI24 offers single-cell resolution profiling that combines transcriptomic, proteomic, and morphological data using Teton™ kits and avidite base chemistry. This technology will be integrated into Gene Solutions' R&D pipelines, including the Clinical Multi-omics Project, 3D Patient-derived Organoids, and a Neoantigen Cancer Vaccine programme. These projects reflect the company’s commitment to applying multi-modal AI and multi-omics to drive forward therapeutic development.

The agreement provides a foundation for further exploration into joint marketing, research and development, technical cooperation, and customer support. By pooling expertise and technological capabilities, both organisations aim to expand access to genomic technologies and accelerate their adoption in clinical and research settings.

This partnership is expected to play a significant role in strengthening the global footprint of both companies, particularly in the application of precision medicine and genomic diagnostics.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!